Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of SEK 3.78 billion. The enterprise value is 3.62 billion.

Market Cap	3.78B
Enterprise Value	3.62B

Important Dates

The last earnings date was Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	18.28M
Shares Outstanding	n/a
Shares Change (YoY)	-0.23%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	2.94%
Owned by Institutions (%)	84.19%
Float	12.62M

Valuation Ratios

The trailing PE ratio is 26.00 and the forward PE ratio is 25.48.

PE Ratio	26.00
Forward PE	25.48
PS Ratio	5.92
PB Ratio	8.84
P/TBV Ratio	11.09
P/FCF Ratio	n/a
P/OCF Ratio	21.61
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	24.85
EV / Sales	5.39
EV / EBITDA	17.79
EV / EBIT	19.24
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.08.

Current Ratio	3.34
Quick Ratio	2.21
Debt / Equity	0.08
Debt / EBITDA	0.18
Debt / FCF	n/a
Interest Coverage	11.65

Financial Efficiency

Return on equity (ROE) is 35.18% and return on invested capital (ROIC) is 52.43%.

Return on Equity (ROE)	35.18%
Return on Assets (ROA)	19.85%
Return on Invested Capital (ROIC)	52.43%
Return on Capital Employed (ROCE)	37.92%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	4.15M
Profits Per Employee	945,281
Employee Count	154
Asset Turnover	1.13
Inventory Turnover	0.80

Taxes

In the past 12 months, Medistim ASA has paid 43.56 million in taxes.

Income Tax	43.56M
Effective Tax Rate	23.03%

Stock Price Statistics

The stock price has increased by +40.58% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+40.58%
50-Day Moving Average	236.80
200-Day Moving Average	n/a
Relative Strength Index (RSI)	48.55
Average Volume (20 Days)	1,079

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of SEK 639.83 million and earned 145.57 million in profits. Earnings per share was 7.97.

Revenue	639.83M
Gross Profit	522.63M
Operating Income	179.39M
Pretax Income	189.13M
Net Income	145.57M
EBITDA	194.04M
EBIT	179.39M
Earnings Per Share (EPS)	7.97

Full Income Statement

Balance Sheet

The company has 193.92 million in cash and 34.29 million in debt, giving a net cash position of 159.63 million.

Cash & Cash Equivalents	193.92M
Total Debt	34.29M
Net Cash	159.63M
Net Cash Per Share	n/a
Equity (Book Value)	428.29M
Book Value Per Share	23.44
Working Capital	305.86M

Full Balance Sheet

Cash Flow

Operating Cash Flow	175.16M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 81.68%, with operating and profit margins of 28.04% and 22.75%.

Gross Margin	81.68%
Operating Margin	28.04%
Pretax Margin	29.56%
Profit Margin	22.75%
EBITDA Margin	30.33%
EBIT Margin	28.04%
FCF Margin	n/a

Dividends & Yields

Medistim ASA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	68.76%
Buyback Yield	0.23%
Shareholder Yield	0.23%
Earnings Yield	3.85%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6